Its difficult to see how the future could have been laid out more clearly and positively.
There are many restraints that the board and CEO operate under, including ASX rules, confidentiality regarding discussions, early results, and possible deals etc.
A couple of snippets if I noted them correctly:
Looking at the competitive landscape: “…in our mind, none of these drugs present a significant competitive threat…….”
Studies to keep an eye on: St Jude DIPG “….a couple of patients in survival follow-up…”
- Forums
- ASX - By Stock
- KZA
- Ann: Chairman's Address to Shareholders
Ann: Chairman's Address to Shareholders, page-14
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)